The i-SIGHT2 pivotal trial is evaluating a noninvasive office-based bioelectric therapy for intermediate to advanced dry age-related macular degeneration. ...
The clearance expands the LifeLens Physiological Monitor beyond ECG acquisition to include respiratory, temperature, activity and gait parameters. ...
SOMNUM V3.0 supports automated analysis of polysomnography data and classifies obstructive, central and mixed sleep apnea events....
The company is preparing a dual FDA 510(k) and CLIA Waiver submission for its Flu A/B and RSV multiplex test on the Co-Dx PCR Pro platform....
The launch includes AgeQ, a first-in-market biological age clinical assessment designed to provide early insights and guidance for healthier ageing....
The Xpert Xpress MVP test helped more women receive appropriate treatment within 24 hours compared with usual diagnostic methods....
The ClearFit AI integrated platform combines sonolucent implant technology, bedside ultrasound imaging, and artificial intelligence to support the future of postoperative brain visualisation...
The initiative will support placement of VMS+ cardiac imaging units to improve congenital heart disease assessment in underserved settings....
The CIZ1B biomarker test is being prepared for near-term availability to U.S. healthcare providers through OmniHealth Diagnostics....
The Xpert Hemorrhagic Fever panel will support decentralised molecular testing during the Ebola Bundibugyo outbreak in DRC and Uganda....
